MITD1

Across TCGA pan-cancer cohorts, MITD1 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MITD1’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where MITD1 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types MITD1 is over-expressed in tumor, although a few such as LUAD show the opposite, repressed pattern.

LUAD and LSCC are the cancer types where MITD1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MITD1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	All	−0.336	<.001	8	view →
LSCC	All	All	+0.083	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

MITD1–LUAD

Open the LUAD breakdown →